Accelera is one of the few Italian companies committed in preclinical research and offers integrated high level services for biotech and pharmaceutical companies, as well as academic Institutes and non-profit organizations, at a worldwide level. We have more than 15 years of experience as CRO for Clients around the world (Europe, South Korea, US, UK) supporting various TA mainly based on Client’s pipelines and new modalities (e.g. cell based therapies). We work equally with small molecules and biologics; all regularly considered test species are available (rodents and non-rodents); all major administration routes are covered. We provide the entire range from proof of concept/efficacy (oncology), preliminary non-GLP tox&safety up to the full GLP tox (including genotox and safety pharmacology), chronic and DART reprotox studies. With over 25 integrated development programs executed in the last few years, we are proud to be working with over 100 Sponsors. The reliability of results and their acceptability worldwide is guaranteed by qualified scientific teams, advanced platforms and technologies located in a wide modular structure and high quality certification by Regulatory Agencies for Good Laboratory Practices (GLP) and AAALAC. Accelera experts are involved in the development and validation of innovative and alternative methods in collaboration with most representative centers of reference and in teaching in higher education programme. Details on Accelera services and more info on expertise & capabilities on: http://www.accelera.org/ info@accelera.org